您要查找的是不是:
- The power of REP-PCR is higher than that of ERIC-PCR in discriminating typing of the Acinetobacter baumannii. 在鲍曼不动杆菌基因同源性分析中,REP-PCR的分辨率较ERIC-PCR高;
- Results:The rate of drug resistance of Acinetobacter baumannii to Imipenem, Meropenem and Cefoperazone/Sulbactam was the lowest (6.82%,9.09%,11.36%). 结果:鲍曼不动杆菌对亚胺培南、美罗培南和头孢哌酮/舒巴坦的耐药率最低;分别为6.;82%25;9
- Objective To determine the disrtibution and resistance of clincal isolates of Acinetobacter baumannii from Bethune International Peace Hospital. 目的了解白求恩国际和平医院临床分离的鲍曼不动杆菌临床感染分布和耐药现状。
- METHODS Analyse antibiotic susceptibility of 122 strains Acinetobacter baumannii in 2001 year detected by Kirby Bauer test with statistics. 方法对应用K-B纸片琼脂扩散法检测的2001年122株鲍曼不动杆菌药敏试验进行统计分析。
- Objective To develop a novel multiplex polymerase chain reaction (PCR) to detect multidrug-resistant Acinetobacter baumannii. 目的建立一种适于临床微生物实验室快速检测多耐药鲍曼不动杆菌基因的多重PCR方法。
- Objective To analyze the plasmid and resistant spectra and the location of the resistance gene of Acinetobacter baumannii . 目的分析鲍氏不动杆菌的质粒谱和耐药谱,找出它们的耐药基因位点。
- Objective: To study the characteristics of antibiotic susceptibility of Acinetobacter baumannii so as to provide basis for clinical application. 摘要目的:了解临床分离的鲍曼不动杆菌的感染特点及耐药情况,为临床抗感染治疗提供依据。
- The results are disturbing because Acinetobacter baumannii has the propensity to develop resistance to almost all available antibiotics. 这一调查结果真是令人担忧。因为鲍氏不动杆菌会对人体的所有有用抗生素造成破坏。
- Results The isolated rates of Pseudomonas aeruginose、Acinetobacter baumannii and Stenotrophomonas maltophilia were 13%、7% and 4% respectively. 结果铜绿假单胞菌、鲍曼不动杆菌和嗜麦芽窄食单胞菌在总体分离菌中分别占13%25、7%25和4%25。
- Objectives To evaluate multidrug-resistant Acinetobacter baumannii's resistance and characteristic of antibiotics therapy. 摘要目的了解多重耐药鲍曼不动杆菌耐药谱和临床特点。
- ABSTRACT Objective To investigate the role of efflux pump of Acinetobacter baumannii mutant strains against fluoroquinolones. 目的探讨主动外排泵在鲍曼不动杆菌诱导突变株对氟喹诺酮类药物敏感性的影响。
- Objective:To find out the antibiotic resistance of Acinetobacter baumannii in ICU and to provide strategies for prevention and treatment. 目的:了解鲍曼不动杆菌在ICU的耐药性,为临床抗感染治疗提供依据。
- The resistance rates of Ampicillin/Sullbactam、Imipenem and Meropenem to Acinetobacter baumannii were lower than those of the other antibiotics. 鲍曼不动杆菌对氨苄西林/舒巴坦、亚胺培南以及美罗增南的耐药率较低;
- Methods To analyze multidrug-resistant and clinical therapy of Acinetobacter baumannii isolated from patients from Dec. 2004 to Sept. 2005 in our nosocomium. 方法分析2004年12月-2005年9月分离自住院患者标本的鲍曼不动杆菌耐药性资料及其治疗情况。
- E.coli and Klebsiella pneumoniae were sensitive to imipenem and meropenem, but Acinetobacter baumannii were resistant to them, whose resistance rate was above 35%. 亚胺培南与美罗培南对大肠埃希菌和肺炎克雷伯菌作用效果较好,但对鲍曼不动杆菌耐药较严重,耐药率达35%25以上。
- Methods To analyze multidrug-resistant and clinical therapy of Acinetobacter baumannii isolated from patients from Jun.2004 to Dec.2006 in our nosocomium. 方法分析2004年6月至2006年12月来自住院患者标本的鲍曼不动杆菌耐药性资料及其治疗情况。
- Objective To study the distribution and drug resistance of Acinetobacter baumannii, and to offer reasonable experimental data for clinical therapeutics. 摘要目的了解鲍曼不动杆菌的感染分布及耐药状况,为临床治疗提供依据。
- Objective To investigate the antimicrobial resistance of acinetobacter baumannii from nosocomial infection in order to choose antibiotics for clinical therapy. 摘要目的探讨鲍曼不动杆菌耐药分布及耐药的新动向为感染的临床治疗提供选药依据。
- Objective To realize the distribution and antimicrobial resistance of Acinetobacter baumannii isolated from a hospital, so as to provide reference for antimicrobial treatment. 目的了解某院鲍曼不动杆菌的耐药现状及标本分布,为治疗提供依据。
- Objective To investigate the character of clinical distribution and the varied situation of drug-resistance of acinetobacter baumannii to guide the clinical use of it. 摘要目的探讨近年来鲍曼不动杆菌的临床分布特点及耐药性变化情况,指导临床用药。